A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis

NCT03002974 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Gouty Arthritis

Interventions

DRUG: Anakinra 100 mg
DRUG: Triamcinolone Acetonide 40 mg
DRUG: Placebo to Anakinra 100 mg
DRUG: Placebo to Triamcinolone Acetonide 40 mg

Sponsor

Swedish Orphan Biovitrum